Exercise and Blood Vessel Function in People With Obesity
Tests whether aerobic exercise changes DNA methylation and vessel function in adults with obesity.
Key facts
- Who runs it
- University of Illinois Chicago
- Where
- Chicago, United StatesSee the site
- Trial code
- Registry title
- DNA Methylation and Vascular Function
- Status
- Recruiting
- People taking part
- 80 people, planned
- Started
- 11 Oct 2019
- Planned end
- 31 Aug 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Exercise training
- Record updated
- 15 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18-50 with a BMI of 35 kg/m2 or more who are approved for bariatric surgery. It studies DNA methylation and blood vessel function.
- Age
- 18 to 50 years
- Sex
- All sexes
- Disease stage
- Obesity with a BMI of 35 kg/m2 or more, approved for a bariatric surgery
Main reasons for not taking part
- Current cancer, heart, kidney or liver disease
- Gallbladder disease
- Acute or chronic inflammatory diseases, including rheumatoid arthritis, lupus and other autoimmune or genetic diseases
- Pregnancy
- Current smokers or current alcohol or drug abuse
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- BMI ≥ 35 kg/m2
- Between ages 18-50 years
- Not pregnant
- Approved for a bariatric surgery
Who cannot take part
- Pregnant women will be excluded, as they will not be eligible for bariatric surgery
- Currently abusing alcohol or drugs
- To avoid confounding from other inflammatory conditions individuals with current cancer, heart, kidney or liver disease, gallbladder disease or acute or chronic inflammatory diseases (including rheumatoid arthritis, lupus and other autoimmune diseases and genetic diseases) will be excluded
- Current smokers
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
Where in United States
- University of Illinois at ChicagoChicago, United StatesContact: Abeer M Mohamed, MD, PhDTaking people
About the trial
What the trial wants to find out
The main objective is to examine DNA hypomethylation as an underlying mechanism for the increased production of inflammatory cytokines and the impaired vascular function in obese individuals and as a potential target for nonpharmacological preventive/therapeutic interventions such as aerobic exercise.
The 2 groups in the trial
- ExercisingExisting treatment, for comparison
12 weeks of aerobic exercise training
Treatment: Exercise training
- Non-exercisingNo study treatment, for comparison
standard of care
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- DNA Methylation and Vascular Function in Obesity: Role of Exercise and Weight Loss
- Plain-language title
- Exercise and Blood Vessel Function in People With ObesityGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Criteria questions
- Built from NCT03527420, who can take part
- Record updated
- 15 September 2025